Selbyville, Delaware , April 19, 2022 (GLOBE NEWSWIRE)
AxisPharm is reported as one of a few prominent company operating in the CRO mass spectroscopy services market.
Resource: https://www.globenewswire.com/en/news-release/2022/04/19/2424136/0/en/CRO-Mass-Spectroscopy-Services-Market-to-hit-USD-1-7-Billion-by-2028-Says-Global-Market-Insights-Inc.html